Stock UK0OCDLSEHealthcareQuality Compounder

Medistim ASA(0OCD) Stock Analysis | Healthcare

NOK --+0.00%

Reward69High

Risk29Low

75%Data

Strong 22% profit margin · 2.9% dividend yield · Revenue growing 20% YoY

NOK —+0.00 (+0.00%) Previous close · LSE

Market cap 4.49Bn

Reward Ratingⓘ69 High reward assessment · 75% data coverage

Top 25% of stocksView factors

Risk Ratingⓘ29 Low risk assessment

Risk factors availableUnlock details

Earnings & dividend markersEarnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Medistim ASA?

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally.

AI Brief Pro

The brief on Medistim ASA

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Medistim ASA?

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 4.49B, and a P/E ratio of 54.1x.